Cargando…
Src-FAK Signaling Mediates Interleukin 6-Induced HCT116 Colorectal Cancer Epithelial–Mesenchymal Transition
Colorectal cancer is one of the most prevalent and lethal malignancies, affecting approximately 900,000 individuals each year worldwide. Patients with colorectal cancer are found with elevated serum interleukin-6 (IL-6), which is associated with advanced tumor grades and is related to their poor sur...
Autores principales: | Huang, Yu-Han, Chen, Han-Kun, Hsu, Ya-Fen, Chen, Hsiu-Chen, Chuang, Chin-Hui, Huang, Shiu-Wen, Hsu, Ming-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095449/ https://www.ncbi.nlm.nih.gov/pubmed/37047623 http://dx.doi.org/10.3390/ijms24076650 |
Ejemplares similares
-
Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells
por: Huang, Yu-Han, et al.
Publicado: (2016) -
The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death
por: Huang, Yu-Han, et al.
Publicado: (2015) -
Peroxiredoxin-6 regulates p38-mediated epithelial–mesenchymal transition in HCT116 colon cancer cells
por: Chae, Unbin, et al.
Publicado: (2021) -
Oligo-Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression
por: Chen, Li-Mei, et al.
Publicado: (2020) -
Tetrandrine Inhibits Epithelial-Mesenchymal Transition in IL-6-Induced HCT116 Human Colorectal Cancer Cells
por: Tsai, Shih-Chang, et al.
Publicado: (2021)